Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.4346
-0.0092 (-2.07%)
May 13, 2025, 9:03 AM - Market open
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $15.78 million as of May 13, 2025. Its market cap has increased by 102.29% in one year.
Market Cap
15.78M
Enterprise Value
13.56M
1-Year Change
102.29%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $15.78M, a decrease of -94.24%. That is a compound annual growth rate of -55.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 16.12M | -27.43% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |